rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2008-6-18
|
pubmed:abstractText |
Familial chronic lymphocytic leukemia (CLL) has the most frequent familial aggregation among hematological malignancies. Familial CLL families have been studied to identify susceptibility genes and other factors that contribute in the etiology of CLL. To date no study has been conducted to evaluate and compare patterns of cell surface antigen expression in familial CLL and sporadic CLL.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1552-4957
|
pubmed:author |
pubmed-author:AhmadEjazE,
pubmed-author:CaporasoNeilN,
pubmed-author:GoldinLynnL,
pubmed-author:HessChristopher JCJ,
pubmed-author:KreitmanRobert JRJ,
pubmed-author:MartiGeraldG,
pubmed-author:SteinbergSeth MSM,
pubmed-author:Stetler-StevensonMaryaliceM,
pubmed-author:WhiteThereseT,
pubmed-author:WiestnerAdrianA,
pubmed-author:WilsonWyndhamW
|
pubmed:issnType |
Electronic
|
pubmed:volume |
74
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
221-6
|
pubmed:dateRevised |
2009-12-11
|
pubmed:meshHeading |
pubmed-meshheading:18431797-Aged,
pubmed-meshheading:18431797-Antigens, CD13,
pubmed-meshheading:18431797-Antigens, CD2,
pubmed-meshheading:18431797-Antigens, CD38,
pubmed-meshheading:18431797-Female,
pubmed-meshheading:18431797-Humans,
pubmed-meshheading:18431797-Immunophenotyping,
pubmed-meshheading:18431797-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:18431797-Male,
pubmed-meshheading:18431797-Membrane Glycoproteins,
pubmed-meshheading:18431797-Middle Aged,
pubmed-meshheading:18431797-Prognosis,
pubmed-meshheading:18431797-Survival Rate
|
pubmed:year |
2008
|
pubmed:articleTitle |
Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia.
|
pubmed:affiliation |
Good Samaritan Hospital, Dayton, Ohio, USA.
|
pubmed:publicationType |
Journal Article
|